Anti-human CCR2 monoclonal antibody, plozalizumab biosimilar

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1016-100ug

  • Size

    100ug

  • Price

    $350

1
This antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
note Other commonly used names in publications refering to this antibody: MLN-1202, MLN1202, anti-CCR2, hu1D9
target CCR2
alias CC-CKR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R
gene id Uniprot ID: P41597
host species Humanized
reactivity Human
iso type Human IgG1 kappa
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml
applications Flow Cyt
dilution Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.

Images

Flow cytometry analysis with 1 ug/mL Anti-CCR2 (plozalizumab biosimilar) mAb on Expi293 cells transfected with Human CCR2 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).


PRODUCT

  • SKU

    DMS1016-100ug

  • Size

    100ug

  • Price

    $350

1